Palivizumab 100MG/m 1S
Ended Awarded
- Contract number
- SPE2DX26FWDTM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $19,118
Award facts
- Contract value 100% obligated
- $19,118.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,118.00 for Palivizumab 100mg on October 7, 2025, with completion expected by October 28, 2025. This competitively awarded, firm fixed-price delivery order was funded through the Defense Logistics Agency's Medical Supply Chain and represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The delivery order carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete successfully for federal medical procurement requirements.
Palivizumab is a monoclonal antibody respiratory syncytial virus (RSV) preventive immunization primarily used to protect high-risk populations, including premature infants and immunocompromised patients. This award exemplifies the Defense Logistics Agency's reliance on AmerisourceBergen as a critical vendor for specialized pharmaceutical products supporting military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its role as a primary supplier of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains for Department of Defense healthcare programs.
Quick answers
Who was awarded contract SPE2DX26FWDTM?
SPE2DX26FWDTM was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on October 7, 2025.
How much is contract SPE2DX26FWDTM worth?
The government has obligated $19,118 on SPE2DX26FWDTM.
Is contract SPE2DX26FWDTM an order under another contract?
Yes. SPE2DX26FWDTM is a delivery order under SPE2DX15D6028, an indefinite delivery contract.
Was contract SPE2DX26FWDTM competed?
The extent of competition for SPE2DX26FWDTM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award